Farag Kameel D.'s Form 4 filing
Akari Therapeutics Plc (AKTX) · filed Aug 5, 2026
- Accession no.
- 0001493152-26-036231
- Filed
- Aug 5, 2026, 6:30 PM ET
- Trade date
- Jul 16, 2026
- Filing delay
- 20 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 20 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Farag Kameel D.CIK 0002093620 | Officer (Interim CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | American Depositary Shares representing Ordinary Shares | AGrant or awardAcquired | +1,130 | $11.50 | +$12,995 | 21,581 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.